p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients

BMC Pulmonary Medicine

Raimundas Sakalauskas¹  Simona Lavinskiene²  Kestutis Malakauskas²  Deimante Hoppenot¹ 

[1] Department of Pulmonology and Immunology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania;Laboratory of Pulmonology, Department of Pulmonology and Immunology, Medical Academ, Lithuanian University of Health Sciences, Kaunas, Lithuania

关键词: Transcription factors;    Eosinophil apoptosis;    Interleukin-9;    Th9 cells;    Allergic asthma;   

Others  :  1229490
DOI  :  10.1186/s12890-015-0119-7

 received in 2015-01-02, accepted in 2015-10-06,  发布年份 2015

【 摘 要 】

Background

Previous in vitro and animal studies demonstrated that transcription factors p-STAT6 and PU.1 are required to induce interleukin (IL)-9 secretion by T helper (Th) 9 cells. It is believed that n factor-kappaB (NF-κB) plays a role in eosinophil survival. The importance of these transcription factors in the pathogenesis of allergic asthma (AA) in humans is poorly understood. We evaluated p-STAT6 and PU.1 expression in peripheral blood Th9 cells and NF-κB expression in eosinophils during late-phase airway inflammation in AA patients.

Methods

Nineteen adults with AA and 14 adult healthy individuals (HI) were examined. Peripheral blood collected 24 h before (baseline) and 24 h after bronchial allergen challenge. CD4 ⁺cells and eosinophils were isolated by high-density gradient centrifugation and magnetic separation. The percentage of Th9 cells and apoptotic eosinophils was estimated by flow cytometry. p-STAT6 and PU.1 expression was expressed as mean fluorescence intensity (MFI) in Th9 cells. NF-κB levels were expressed as MFI in peripheral blood eosinophils. Serum IL-9 and IL-5 levels were determined by enzyme-linked immunosorbent assay.

Results

At baseline, MFI of p-STAT6 and PU.1 in peripheral blood Th9 cells and MFI of NF-κB in eosinophils and, serum IL-5 and IL-9 levels were greater in AA patients (P < 0.05). Decreased eosinophil apoptosis was seen in the AA group compared with HI (P < 0.05). MFI of p-STAT6, PU.1, and NF-κB and serum levels of IL-5 and IL-9 were increased in the AA group 24 h after challenge compared with baseline (P < 0.05). In the AA group, a correlation between serum IL-9 and Th9 cells (r = 0.7, P = 0.001) and MFI of PU.1 (r = 0.6, P = 0.01) 24 h after bronchial allergen challenge was observed. A correlation between Th9 cells and MFI of p-STAT6 (r = 0.45, P = 0.03) as well as MFI of PU.1 (r = 0.5, P = 0.02) 24 h after challenge was only observed in AA patients. A correlation between the MFI of NF-κB and eosinophil apoptosis was observed in AA patients 24 h before (r = −0.46, P = 0.02) and after (r = −0.5, P = 0.02) challenge.

Discussions

p-STAT6 and PU.1 may be associated with Th9 cells and IL-9 production, whereas NF-κB and IL-5 may be associated with reduced eosinophil apoptosis in allergen-induced late-phase airway inflammation.

Trial registration

ClinicalTrials.gov NCT02214303

【 授权许可】

   
2015 Hoppenot et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

【 参考文献 】

• [1]Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006; 355(21):2226-2235.
• [2]Durrant DM, Metzger DW. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest. 2010; 39(4–5):526-549.
• [3]Wan YY. Multi-tasking of helper T cells. Immunology. 2010; 130(2):166-171.
• [4]Trivedi SG, Lloyd CM. Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci. 2007; 64(10):1269-1289.
• [5]Kroegel C. The role of eosinophils in asthma. Lung. 1990; 168 Suppl:5-17.
• [6]Paul WE. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found Symp. 1997; 204:208-216.
• [7]Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE et al.. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med. 1995; 181(5):1755-1762.
• [8]Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009; 27:485-517.
• [9]Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J et al.. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-1346.
• [10]Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA et al.. IL-4 inhibits TGF-beta-induced Foxp3+ T cells, and together with TGF-beta, generates IL-9+ IL-10+ Foxp3(−) effector T cells. Nat Immunol. 2008; 9(12):1347-1355.
• [11]Jabeen R, Kaplan MH. The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol. 2012; 24(3):303-307.
• [12]Lu Y, Hong S, Li H, Park J, Hong B, Wang L et al.. Th9 cells promote antitumor immune responses in vivo. J Clin Invest. 2012; 122(11):4160-4171.
• [13]Yao W, Tepper RS, Kaplan MH. Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol. 2011; 128:1357-1360.
• [14]Goswami R, Jabeen R, Yagi R, Pham D, Zhu J, Goenka S et al.. STAT6-dependent regulation of Th9 development. J Immunol. 2012; 188(3):968-975.
• [15]Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N et al.. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity. 2010; 33(2):192-202.
• [16]Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A et al.. Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest. 2013; 123(11):4641-4653.
• [17]Ramming A, Druzd D, Leipe J, Schulze-Koops H, Skapenko A. Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development. Blood. 2012; 119(20):4665-4674.
• [18]Hamid QA, Minshall EM. Molecular pathology of allergic disease: I: lower airway disease. J Allergy Clin Immunol. 2000; 105(1 Pt 1):20-36.
• [19]Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol. 1999; 104(5):917-926.
• [20]Ricci M, Matucci A, Rossi O. Bronchial asthma: pathogenetic mechanisms and genetic aspects. Recenti Prog Med. 1997; 88(11):530-540.
• [21]Tai PC, Sun L, Spry CJ. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol. 1991; 85(2):312-316.
• [22]Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E et al.. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood. 2000; 96(6):2163-2171.
• [23]Fujihara S, Jaffray E, Farrow SN, Rossi AG, Haslett C, Hay RT. Inhibition of NF-kappa B by a cell permeable form of I kappa B alpha induces apoptosis in eosinophils. Biochem Biophys Res Commun. 2005; 326(3):632-637.
• [24]Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al.. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31(1):143-178.
• [25]Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al.. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-968.
• [26]Baur X, Huber H, Degens PO, Allmers H, Ammon J. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med. 1998; 33(2):114-122.
• [27]Dreborg S. The skin prick test in the diagnosis of atopic allergy. J Am Acad Dermatol. 1989; 21(4 Pt 2):820-821.
• [28]Liu L, Jarjour NN, Busse WW, Kelly EA. Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. Am J Respir Crit Care Med. 2004; 169(10):1118-1124.
• [29]Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S et al.. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol. 1994; 153(9):3989-3996.
• [30]Hegazy AN, Peine M, Helmstetter C, Panse I, Frohlich A, Bergthaler A et al.. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity. 2010; 32(1):116-128.
• [31]Perumal NB, Kaplan MH. Regulating Il9 transcription in T helper cells. Trends Immunol. 2011; 32(4):146-150.
• [32]Wong MT, Ye JJ, Alonso MN, Landrigan A, Cheung RK, Engleman E et al.. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol. 2010; 88(6):624-631.
• [33]Putheti P, Awasthi A, Popoola J, Gao W, Strom TB. Human CD4 memory T cells can become CD4 + IL-9+ T cells. PLoS One. 2010; 5(1): Article ID e8706
• [34]Zhao P, Xiao X, Ghobrial RM, Li XC. IL-9 and Th9 cells: progress and challenges. Int Immunol. 2013; 25(10):547-551.
• [35]Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol. 2012; 129(4):1000-1010.
• [36]Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL et al.. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010; 11(6):527-534.
• [37]Wurster AL, Tanaka T, Grusby MJ. The biology of Stat4 and Stat6. Oncogene. 2000; 19(21):2577-2584.
• [38]Sehra S, Bruns HA, Ahyi AN, Nguyen ET, Schmidt NW, Michels EG et al.. IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6. J Immunol. 2008; 180(5):3551-3559.
• [39]Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y et al.. Interleukin 9 promotes influx and local maturation of eosinophils. Blood. 2001; 97(4):1035-1042.
• [40]Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med. 1998; 188(7):1307-1320.
• [41]Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ et al.. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol. 2012; 13(10):981-990.
• [42]Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN et al.. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem. 1999; 274(7):4309-4318.
• [43]Temkin V, Levi-Schaffer F. Mechanism of tumour necrosis factor alpha mediated eosinophil survival. Cytokine. 2001; 15(1):20-26.
• [44]Kankaanranta H, Ilmarinen P, Zhang X, Adcock IM, Lahti A, Barnes PJ et al.. Tumour necrosis factor-alpha regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-kappaB and AP-1. PLoS One. 2014; 9(2): Article ID e90298
• [45]Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther. 2009; 121(1):1-13.
• [46]Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol. 2000; 106(1 Pt 1):77-83.
• [47]Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol. 1997; 100(4):536-543.